Moderna's average Accounts Receivable for the
three
months ended in Dec. 2023 was $1,379 Mil. Moderna's Revenue for the
three
months ended in Dec. 2023 was $2,813 Mil.
Hence, Moderna's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 44.73.
The historical rank and industry rank for Moderna's Days Sales Outstanding or its related term are showing as below:
MRNA'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 29.58 Med: 52.49 Max: 932.79
Current: 59.32
During the past 8 years, Moderna's highest Days Sales Outstanding was 932.79. The lowest was 29.58. And the median was 52.49.
MRNA's Days Sales Outstanding is ranked better than 59.73% of 889
companies
in the Biotechnology industry
Industry Median: 71.83
vs MRNA: 59.32
Moderna's Days Sales Outstanding
increased
from Dec. 2022 (36.15) to Dec. 2023 (44.73).
Moderna Days Sales Outstanding Historical Data
The historical data trend for Moderna's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Moderna's Days Sales Outstanding
For the Biotechnology subindustry, Moderna's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moderna's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moderna's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Moderna's Days Sales Outstanding falls into.
Moderna Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moderna (NAS:MRNA) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Moderna Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Moderna's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MRNA has been successfully added to your 